Filing Details
- Accession Number:
- 0001787306-24-000157
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-18 19:04:23
- Reporting Period:
- 2024-11-14
- Accepted Time:
- 2024-11-18 19:04:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1787306 | Arcutis Biotherapeutics Inc. | ARQT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741987 | Patrick Burnett | C/O Arcutis Biotherapeutics, Inc. 3027 Townsgate Road Suite 300 Westlake Village CA 91361 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-14 | 50,749 | $10.29 | 128,669 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 18,377 | $0.00 | 147,046 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-14 | 18,377 | $10.29 | 128,669 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-11-15 | 100 | $0.00 | 128,769 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-15 | 100 | $10.03 | 128,669 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-11-14 | 18,377 | $0.00 | 18,377 | $3.64 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-11-15 | 100 | $0.00 | 100 | $3.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 234,623 | 2034-01-12 | No | 4 | M | Direct | |
| 234,523 | 2034-01-12 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $10.4926 to $10.00, inclusive. The Reporting Person herebyundertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respectiveprice within the range set forth in this footnote.
- On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
Billionaire Hedge Funds
